This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Waterloo directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Neuropharmacology of Nicotine Addiction and Therapeutic Strategies for Smoking Cessation.
Biology · 2026
Surface electrostatic networks control hydrophobic core remodeling in a pH-dependent switching protein.
bioRxiv : the preprint server for biology · 2026
P4ward: An Automated Modeling Platform for Protac Ternary Complexes.
Journal of chemical information and modeling · 2025 · senior author
Latest funding
- $15,000
A Carbonic Anhydrase with High Stability and Catalytic Efficiency for Carbon Capture Systems
NSERC · 2025 · Principal investigator
- $125,000
Enzyme-laden smart-coating technology to eliminate microplastics
SSHRC · 2024 · Co-investigator
- $111,000
An integrated computational framework for protein engineering and novel biocatalyst design
NSERC · 2022 · Principal investigator
23 publications.
Neuropharmacology of Nicotine Addiction and Therapeutic Strategies for Smoking Cessation.
Hefny AA, Karuturi RC, Kalyaanamoorthy S, Rao PPN, Ganesan A
Surface electrostatic networks control hydrophobic core remodeling in a pH-dependent switching protein.
McDonald IMH, Socas LBP, Walton-Raaby M, Liu X, Dasari S, Emmanuel BG, Butt MS, Kalyaanamoorthy S, Brooks CL, Meiering EM
P4ward: An Automated Modeling Platform for Protac Ternary Complexes.
Jofily P, Kalyaanamoorthy S
Angiostatin-a novel SARS-CoV-2 inhibitor and biomarker underlying COVID-19 pathophysiology.
Franczak A, Joyce M, Lopez-Orozco J, Saffran HA, Saito M, Asgari A, Kalyaanamoorthy S, Barakat K, Hobman TC, Tyrrell DL, Jurasz P
Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy.
Wang J, Forrest SL, Dasari S, Tanaka H, Rogaeva E, Tartaglia MC, Fox S, Lang AE, Kalyaanamoorthy S, Kovacs GG
Revealing the impact of active site residues in modeling the inhibition mechanism of SARS-Cov-2 main protease by GC373.
Aboelnga MM, Petgrave M, Kalyaanamoorthy S, Ganesan A
Impact of Phosphorylation and O-GlcNAcylation on the Binding Affinity of R4 Tau Peptide to Microtubule and Its Conformational Preference upon Dissociation.
Dasari S, Kalyaanamoorthy S
Allosteric inhibition of tRNA synthetase Gln4 by N-pyrimidinyl-β-thiophenylacrylamides exerts highly selective antifungal activity
Puumala E, Sychantha D, Lach E, Reeves S, Nabeela S, Fogal M, Nigam A, Johnson JW, Aspuru-Guzik A, Shapiro RS
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.
Kalyaanamoorthy S, Opare SK, Xu X, Ganesan A, Rao PPN
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease.
Tran N, Dasari S, Barwell SAE, McLeod MJ, Kalyaanamoorthy S, Holyoak T, Ganesan A
A Carbonic Anhydrase with High Stability and Catalytic Efficiency for Carbon Capture Systems
Principal investigators: Kalyaanamoorthy, Subha S
Keywords: biocatalyst; carbon di oxide capture; carbonic anhydrase; enzyme engineering; protein
Enzyme-laden smart-coating technology to eliminate microplastics
Principal investigators: Musselman, Kevin
An integrated computational framework for protein engineering and novel biocatalyst design
Principal investigators: Kalyaanamoorthy, Subha
Keywords: enzymes; molecular dynamics; protein sequence, structure, function; substrate binding; molecular docking; ancestral sequence reconstruction; plastic degradation; protein engineering; rational design of enzymes; catalytic mechanisms
An integrated computational framework for protein engineering and novel biocatalyst design
Principal investigators: Kalyaanamoorthy, Subha
Evolution-guided engineering of novel nanobiocatalyst for carbon dioxide sequestration
Principal investigators: Kalyaanamoorthy, Subha
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Aravindhan Ganesan and Subha Kalyaanamoorthy: 10 shared papers
- Michael Houghton and Khaled Barakat: 7 shared papers
- Ekaterina Rogaeva and Susan Fox: 3 shared papers
- Jakob Magolan and Gerard Wright: 2 shared papers
- Khaled Barakat and Subha Kalyaanamoorthy: 2 shared papers
- Jakob Magolan and Subha Kalyaanamoorthy: 1 shared paper
- Gerard Wright and Subha Kalyaanamoorthy: 1 shared paper
- Peter Light and Subha Kalyaanamoorthy: 1 shared paper
- Paul Jurasz and Khaled Barakat: 1 shared paper
- Paul Jurasz and Subha Kalyaanamoorthy: 1 shared paper
- Ekaterina Rogaeva and Subha Kalyaanamoorthy: 1 shared paper
- Michael Houghton and Subha Kalyaanamoorthy: 1 shared paper
- Khaled Barakat and Aravindhan Ganesan: 1 shared paper
- Susan Fox and Subha Kalyaanamoorthy: 1 shared paper
- Anand Krishnan and Subha Kalyaanamoorthy: 1 shared paper
- Todd Holyoak and Aravindhan Ganesan: 1 shared paper
- Todd Holyoak and Subha Kalyaanamoorthy: 1 shared paper
- Biochemistry & Biomedical Sciences
- Chemistry
- School of Pharmacy
- Pharmacy and Pharmaceutical Science, Faculty of
- Department of Anatomy, Physiology, and Pharmacology
- Tanz Centre for Research in Neurodegenerative Diseases
- Medicine
- Other
Co-authors at University of Waterloo, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Aravindhan Ganesan
School of Pharmacy
10 shared papers, latest 2026
Khaled Barakat
Pharmacy and Pharmaceutical Science, Faculty of
2 shared papers, latest 2025
Peter Light
Pharmacology
1 shared papers, latest 2021
Paul Jurasz
Faculty
1 shared papers, latest 2025
Ekaterina Rogaeva
Tanz Centre for Research in Neurodegenerative Diseases
1 shared papers, latest 2025
Jakob Magolan
Biochemistry & Biomedical Sciences
1 shared papers, latest 2024
Susan Fox
Faculty
1 shared papers, latest 2025
Anand Krishnan
Department of Anatomy, Physiology, and Pharmacology
1 shared papers, latest 2023
Todd Holyoak
Biology
1 shared papers, latest 2023
Michael Houghton
Medicine
1 shared papers, latest 2020
Gerard Wright
Biochemistry & Biomedical Sciences
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.